About Micronbrane Medical
Micronbrane Medical develops technologies that improve the performance of metagenomic next-generation sequencing (mNGS) for microbiology and infectious disease applications. The company focuses on overcoming common challenges associated with mNGS, including host background interference, environmental contamination and low microbial signal recovery. Its technologies support the detection and characterization of microorganisms from complex sample types, enabling researchers to identify pathogens, investigate host-microbe interactions, monitor antimicrobial resistance and study microbial communities. Micronbrane Medical’s platforms are used across infectious disease research, clinical microbiology, microbiome studies, biotechnology development and public health surveillance.
The company’s portfolio includes metagenomic collection devices, host depletion technologies, mNGS-grade reagents, sequencing assays, automation instruments and bioinformatics tools designed to streamline metagenomic workflows. Notable products include the Devin™ Host Depletion filters, which enhance microbial signal recovery by reducing host-derived nucleic acids, and the PaRTI-Seq assay, which supports sensitive microbial detection while minimizing sequencing contamination. These technologies help improve sequencing efficiency, data quality and workflow reproducibility across a range of research and diagnostic applications.
Europa Biosite subsidiaries distribute Micronbrane Medical products in Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxemburg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.